Morning Overview on MSN
Eli Lilly’s new Zepbound pen packs a full month of obesity doses
Eli Lilly and Company (NYSE: LLY) announced on February 23, 2026, that the U.S. Food and Drug Administration has approved a ...
Jasmine Rose is an elegant, timeless fragrance that blends jasmine with notes of peony, rose, and musk. This new format is ...
In today’s Pharma Pulse, Eli Lilly launches the monthly Zepbound KwikPen to streamline obesity care, while Gilead Sciences moves to acquires Arcellx in a massive expansion of its cell therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results